Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 8,949 | 5,663 | 2,759 | 2,082 | 1,582 |
| Cost of Goods | 5,187 | 3,371 | 1,356 | 1,225 | 1,007 |
| Gross Profit | 3,763 | 2,292 | 1,403 | 856 | 575 |
| Operating Expenses | 4,235 | 3,605 | 2,968 | 2,476 | 2,869 |
| Operating Income | -285 | -942 | -1,210 | -1,394 | -2,287 |
| Interest Expense | 742 | 733 | 671 | 588 | 488 |
| Other Income | -57 | 16 | -76 | -1 | 7 |
| Pre-tax Income | -1,084 | -1,660 | -1,957 | -1,984 | -2,768 |
| Net Income Continuous | -1,084 | -1,660 | -1,957 | -1,984 | -2,768 |
| Net Income | $-1,084 | $-1,660 | $-1,957 | $-1,984 | $-2,768 |
| EPS Basic Total Ops | -0.22 | -0.33 | -0.42 | -0.42 | -0.56 |
| EPS Basic Continuous Ops | -0.22 | -0.33 | -0.39 | -0.40 | -0.56 |
| EPS Diluted Total Ops | -0.22 | -0.33 | -0.42 | -0.42 | -0.56 |
| EPS Diluted Continuous Ops | -0.22 | -0.33 | -0.39 | -0.40 | -0.56 |
| EBITDA(a) | $18 | $-694 | $-1,038 | $-1,323 | $-2,194 |